|

Evaluation of Urinary Exosomes Presence From Clear Cell Renal Cell Carcinoma

RECRUITINGSponsored by Centre Hospitalier Universitaire de Saint Etienne
Actively Recruiting
SponsorCentre Hospitalier Universitaire de Saint Etienne
Started2020-01-29
Est. completion2026-08-01
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

Clear cell renal cell carcinoma is diagnosed by imaging, sometimes associated with biopsy. This diagnosis is expensive, invasive and sometimes late. The development of a simple biological test for diagnosis is essential. Exosomes are 30 to 150 nm membrane vesicles secreted into the extracellular space by various living cells. These exosomes can be isolated from biological fluids, including urine. The recent study of urinary exosomes is a promising topic for analyzing tumor markers in urine. The investigator's goal is to develop a reliable technique for detecting tumor exosomes in urine in patients with clear cell renal cell carcinoma. The analysis of urinary exosomes could provide a new liquid biopsy tool for the early diagnosis of clear cell renal cell carcinoma.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

Patients:

* All patients with renal mass requiring surgery (partial or total nephrectomy)
* Social security affiliation
* Signed informed consent

Control :

* Unscheduled nephrectomy
* Social security affiliation
* Signed informed consent

Exclusion Criteria:

* Insufficient volume of urine sample (\< 100 ml)
* Patients with a urinary catheter
* Patients under court-ordered guardianship or curators

Conditions2

CancerClear Cell Renal Cell Carcinoma

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.